Dr. Mir Rauf Subla, MD

Dr. Subla practices at UnityPoint Health- St. Luke’s-Downtown in Sioux City, Iowa.

Dr. Subla's NPI, 1871577379, was assigned on November 30, 2005. Dr. Subla holds North Dakota license 16870.

Dr. Subla's primary practice is UnityPoint Health- St. Luke’s-Downtown, at 801 5th St, Sioux City, IA 51101 in Woodbury County. The practice phone is (712) 279-2010.

Dr. Subla's primary practice is UnityPoint Health- St. Luke’s-Downtown in Sioux City, Iowa. Dr. Subla is also affiliated with UnityPoint Health - St. Luke's. The medical group on file is UnityPoint Health - St. Luke's (St. Luke's Regional Medical Center). Dmand AI also links Dr. Subla to 6 more hospitals, 7 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subla practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Subla's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Subla's licenses on file in 4 states: North Dakota, Iowa, Minnesota and Wisconsin.

CMS data shows 3,166 Medicare services from Dr. Subla across 29 procedure codes in 2024, for 1,264 Medicare patients. Medicare paid $127,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,264 Medicare patients who saw Dr. Subla in 2024. The largest group is 65 to 74, with 491 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subla's median patient age at 73, with 44% women.

In 2024, Dr. Subla wrote 1,564 Medicare Part D claims for 429 patients. 88% of them were for generic drugs. CMS names the drug for 1,423 of them, across 26 drugs with 11 or more claims each, at $156,024 in total drug cost. In 2023, CMS named 1,142 claims across 27 drugs.

Dr. Subla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of coronary angioplasty and stenting by Dr. Subla, more than 93% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 69 general payments to Dr. Subla from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 55% of the total. Edwards Lifesciences Corporation paid the most, $2,249.